As already shown in the HNSCC cohort from TCGA [24], no association between CTLA4 methylation and overall survival in this cohort could be observed (HR = 1.01 [95%CI 0.98–1.03], p = 0.67). This evidence concerns the gene CTLA4 and head and neck squamous cell carcinoma.